Asia Stem Cell Center

Diabetes

Autologus MSC bone marrow stem cell and allogenic pancreatic stem cell for repair of beta pancreatic cell in experimental diabetes mellitus

Alternative therapies in diabetes mellitus (DM) management include the use of stem cells. Stem cells derived from the bone marrow and pancreatic cells from allogenic donors were used in this experimental animal model to restore glucose control. DM was induced in Wistar rats with 50 mg/kg alloxan. DM rats were divided into 4 treatment groups, […]

Autologus MSC bone marrow stem cell and allogenic pancreatic stem cell for repair of beta pancreatic cell in experimental diabetes mellitus Read More »

Adipose-Derived Mesenchymal Stem Cells for Treatment Tertiary Failure Diabetes Mellitus Type 2

Recent progress in diabetes mellitus therapy has focused attention on generation of surrogate β-cells from mesenchymal stem cells (MSCs) derived adult tissues. In this study, we conducted a phase I clinical trial in patients with type 2 diabetes mellitus in various age between 30- 79 years old who were treated with autologous adipose-derived MSCs transplantation.

Adipose-Derived Mesenchymal Stem Cells for Treatment Tertiary Failure Diabetes Mellitus Type 2 Read More »